| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Joselyn Rojas | Q86538033 |
| Juan Salazar | Q86538035 | ||
| Valmore P Bermúdez | Q79303809 | ||
| P2093 | author name string | Antonio Ferreira | |
| Eliana Luzardo | |||
| José Carlos Mejías | |||
| José Ramón Rivas-Ríos | |||
| P2860 | cites work | Novel path to activation of vascular smooth muscle cells: up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor | Q22010614 |
| The Potential Relevance of the Multiple Lipid-Independent (Pleiotropic) Effects of Statins in the Management of Acute Coronary Syndromes | Q22252405 | ||
| Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase | Q24309462 | ||
| Intricate Transcriptional Networks of Classical Brown and Beige Fat Cells | Q26796204 | ||
| Macrophage-secreted factors induce adipocyte inflammation and insulin resistance | Q40326610 | ||
| Insulin action and the insulin signaling network | Q40545115 | ||
| Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. | Q40576701 | ||
| Interleukin-6 induces cellular insulin resistance in hepatocytes | Q40687381 | ||
| Inflammatory genes in epicardial fat contiguous with coronary atherosclerosis in the metabolic syndrome and type 2 diabetes: changes associated with pioglitazone | Q42011233 | ||
| Insulin receptor substrate 2 plays diverse cell-specific roles in the regulation of glucose transport | Q42474195 | ||
| Association of epicardial fat with cardiovascular risk factors and incident myocardial infarction in the general population: the Heinz Nixdorf Recall Study | Q43474965 | ||
| New inflammatory predictors for non-valvular atrial fibrillation: echocardiographic epicardial fat thickness and neutrophil to lymphocyte ratio | Q43519936 | ||
| Epicardial adipose tissue as a source of nuclear factor-kappaB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease | Q43607342 | ||
| Increased volume of epicardial fat is an independent risk factor for accelerated progression of sub-clinical coronary atherosclerosis | Q43668782 | ||
| Exclusive action of transmembrane TNF alpha in adipose tissue leads to reduced adipose mass and local but not systemic insulin resistance | Q43920014 | ||
| Role of ceramide in TNF-alpha-induced impairment of endothelium-dependent vasorelaxation in coronary arteries | Q44182978 | ||
| Echocardiographic Epicardial Adipose Tissue Is Related to Anthropometric and Clinical Parameters of Metabolic Syndrome: A New Indicator of Cardiovascular Risk | Q44960311 | ||
| Effect of epicardial adipose tissue on diastolic functions and left atrial dimension in untreated hypertensive patients with normal systolic function. | Q45342697 | ||
| Race and epicardial fat: the impact of anthropometric measurements, percent body fat and sex. | Q45842877 | ||
| The statins in preventive cardiology. | Q46006532 | ||
| Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study | Q46796587 | ||
| Adipocitokines, adipose tissue and its relationship with immune system cells | Q46870910 | ||
| Comparison of epicardial, abdominal and regional fat compartments in response to weight loss | Q47188314 | ||
| Stimulated HSP90 binding to eNOS and activation of the PI3-Akt pathway contribute to globular adiponectin-induced NO production: vasorelaxation in response to globular adiponectin | Q81751260 | ||
| Epicardial adipose tissue adiponectin expression is related to intracoronary adiponectin levels | Q82579828 | ||
| Cardiovascular magnetic resonance | Q82832934 | ||
| Relationship between epicardial fat measured by 64-multidetector computed tomography and coronary artery disease | Q83452166 | ||
| Epicardial and pericardial fat: close, but very different | Q83559349 | ||
| [The role of innate immunity in obesity] | Q83996176 | ||
| Epicardial adipose tissue and intracoronary adrenomedullin levels in coronary artery disease | Q84273100 | ||
| Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue | Q84517983 | ||
| [Adipocytokines: emerging mediators of the immune response and inflammation] | Q84601085 | ||
| Effect of sitagliptin on epicardial fat thickness in subjects with type 2 diabetes and obesity: a pilot study | Q85696210 | ||
| Epicardial fat volume correlates with severity of coronary artery disease in nonobese patients | Q86524365 | ||
| Impact of duration and dosage of statin treatment and epicardial fat thickness on the recurrence of atrial fibrillation after electrical cardioversion | Q87584777 | ||
| Epicardial fat: definition, measurements and systematic review of main outcomes | Q26823115 | ||
| Obesity associated hypertension: new insights into mechanism | Q26827389 | ||
| Innate immunity and cardiomyocytes in ischemic heart disease | Q27003911 | ||
| Adipocytokines and obesity-linked disorders | Q27021977 | ||
| Tumor necrosis factor alfa in cardiovascular diseases: molecular biology and genetics | Q27023889 | ||
| Regulation of vascular tone by adipocytes | Q27691400 | ||
| TNF-R1 signaling: a beautiful pathway | Q28201944 | ||
| Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study | Q28280445 | ||
| Brown adipose tissue thermogenesis: interdisciplinary studies | Q28331133 | ||
| The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity | Q28506782 | ||
| Brown adipose tissue: function and physiological significance | Q29547448 | ||
| Cellular mechanisms of insulin resistance | Q29619549 | ||
| Adipose tissue as an endocrine organ | Q29620407 | ||
| From cytokine to myokine: the emerging role of interleukin-6 in metabolic regulation. | Q30361595 | ||
| Relationship between epicardial adipose tissue, coronary artery disease and adiponectin in a Mexican population | Q30430889 | ||
| Association between increased epicardial adipose tissue volume and coronary plaque composition | Q30431000 | ||
| p38 mitogen-activated protein kinase: a critical node linking insulin resistance and cardiovascular diseases in type 2 diabetes mellitus | Q30447995 | ||
| Biological and clinical roles of adrenomedullin in circulation control and cardiovascular diseases | Q33673678 | ||
| Epicardial adipose tissue and pericoronary fat thickness measured with 64-multidetector computed tomography: potential predictors of the severity of coronary artery disease | Q33729571 | ||
| Crosstalk between perivascular adipose tissue and blood vessels. | Q33746394 | ||
| Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. | Q33898507 | ||
| The relation of location-specific epicardial adipose tissue thickness and obstructive coronary artery disease: systemic review and meta-analysis of observational studies | Q33914013 | ||
| Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents | Q33915940 | ||
| Adipose tissue and vascular inflammation in coronary artery disease | Q33948483 | ||
| Benefits of healthy adipose tissue in the treatment of diabetes | Q34023537 | ||
| Links between ectopic fat and vascular disease in humans | Q34076155 | ||
| Tumor necrosis factor signaling. | Q34185821 | ||
| Recent advances in our understanding of insulin action and insulin resistance | Q34209698 | ||
| MAPK signalling in cellular metabolism: stress or wellness? | Q34255390 | ||
| Human epicardial adipose tissue is a source of inflammatory mediators | Q34272633 | ||
| Epicardial and perivascular adipose tissues and their influence on cardiovascular disease: basic mechanisms and clinical associations. | Q34297183 | ||
| The impact of epicardial fat volume on coronary plaque vulnerability: insight from optical coherence tomography analysis. | Q51433446 | ||
| Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. | Q51469352 | ||
| Mapping epicardial fat with multi-detector computed tomography to facilitate percutaneous transepicardial arrhythmia ablation. | Q51822179 | ||
| Epicardial adipose tissue is associated with visceral fat, metabolic syndrome, and insulin resistance in menopausal women. | Q51831047 | ||
| Epicardial adipose tissue, hepatic steatosis and obesity. | Q51909922 | ||
| Measurement of epicardial fat thickness by transthoracic echocardiography for predicting high-risk coronary artery plaques. | Q52977998 | ||
| Clinical Utility of Measuring Epicardial Adipose Tissue Thickness with Echocardiography Using a High-Frequency Linear Probe in Patients with Coronary Artery Disease. | Q52991641 | ||
| Increased epicardial fat tissue is a marker of metabolic syndrome in adult patients. | Q53202167 | ||
| [Regional distribution of the body fat: use of image techniques as tools for nutritional diagnosis]. | Q53296627 | ||
| Epicardial adipose tissue and coronary artery plaque characteristics. | Q53317786 | ||
| Aerobic exercise training reduces epicardial fat in obese men. | Q53390665 | ||
| Uncoupling protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat. | Q53503941 | ||
| Body Composition and Epicardial Fat in Type 2 Diabetes Patients Following Insulin Detemir Versus Insulin Glargine Initiation. | Q53673886 | ||
| "Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. | Q53856346 | ||
| Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells. | Q55043111 | ||
| Adiponectin is a novel humoral vasodilator | Q56981922 | ||
| Obesity in the new millennium | Q59070727 | ||
| Site-specific properties of pericardial and epicardial adipose tissue: the effects of insulin and high-fat feeding on lipogenesis and the incorporation of fatty acids in vitro | Q70266824 | ||
| Endothelins | Q71874242 | ||
| Adrenomedullin stimulates two signal transduction pathways, cAMP accumulation and Ca2+ mobilization, in bovine aortic endothelial cells | Q72591904 | ||
| Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma | Q72771006 | ||
| Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells | Q73832971 | ||
| Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction | Q78969770 | ||
| A relationship between echocardiographic subepicardial adipose tissue and metabolic syndrome | Q80559487 | ||
| Relation between epicardial adipose tissue and left ventricular mass | Q80846003 | ||
| Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease | Q81480879 | ||
| Adaptive thermogenesis in adipocytes: is beige the new brown? | Q34326605 | ||
| Brown and beige fat: development, function and therapeutic potential | Q34375850 | ||
| Epicardial adipose tissue thickness correlates with the presence and severity of angiographic coronary artery disease in stable patients with chest pain | Q34379566 | ||
| Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. | Q34420472 | ||
| Regulation of cardiac and smooth muscle Ca(2+) channels (Ca(V)1.2a,b) by protein kinases | Q34430875 | ||
| Molecular insights into the role of white adipose tissue in metabolically unhealthy normal weight and metabolically healthy obese individuals | Q34448725 | ||
| Effects of statins on the epicardial fat thickness in patients with coronary artery stenosis underwent percutaneous coronary intervention: comparison of atorvastatin with simvastatin/ezetimibe | Q34495566 | ||
| Endothelin-1 and endothelin receptor antagonists as potential cardiovascular therapeutic agents | Q34496108 | ||
| Cardioprotective properties of omentin-1 in type 2 diabetes: evidence from clinical and in vitro studies. | Q34651892 | ||
| Perivascular adipose tissue and its role in type 2 diabetes and cardiovascular disease | Q34902082 | ||
| Perivascular adipose tissue and vascular disease | Q35047205 | ||
| Resistin: functional roles and therapeutic considerations for cardiovascular disease | Q35859749 | ||
| Epicardial perivascular adipose tissue as a therapeutic target in obesity-related coronary artery disease | Q35859756 | ||
| Usefulness of the epicardial fat tissue thickness as a diagnostic criterion for geriatric patients with metabolic syndrome | Q36011300 | ||
| Adiposity of the heart, revisited | Q36439598 | ||
| Recent advances in the relationship between obesity, inflammation, and insulin resistance. | Q36448850 | ||
| Calcium cycling proteins and heart failure: mechanisms and therapeutics | Q36497155 | ||
| Regulatory circuits controlling white versus brown adipocyte differentiation | Q36561080 | ||
| Role of insulin resistance in endothelial dysfunction | Q36674069 | ||
| Myocardial, perivascular, and epicardial fat | Q36783911 | ||
| Adrenomedullin is a novel adipokine: adrenomedullin in adipocytes and adipose tissues. | Q36791256 | ||
| Epicardial fat: properties, function and relationship to obesity | Q36795877 | ||
| Ryanodine receptors, voltage-gated calcium channels and their relationship with protein kinase A in the myocardium. | Q36804372 | ||
| MAP kinases and the control of nuclear events | Q36819401 | ||
| Inflammation, obesity, and the metabolic syndrome | Q36977858 | ||
| Role of TNF-alpha in vascular dysfunction | Q37050343 | ||
| APPL1: role in adiponectin signaling and beyond | Q37086421 | ||
| Epicardial adipose tissue has a unique transcriptome modified in severe coronary artery disease | Q37214767 | ||
| Adipose tissue dysfunction in obesity, diabetes, and vascular diseases | Q37262617 | ||
| Relationship of epicardial adipose tissue thickness with early indicators of atherosclerosis and cardiac functional changes in obese adolescents with metabolic syndrome | Q37271516 | ||
| Obesity, inflammation and diet | Q37285746 | ||
| Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine | Q37328316 | ||
| Cardiovascular actions of adiponectin: pathophysiologic implications | Q37396415 | ||
| Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications | Q37536067 | ||
| Adipokines: a link between obesity and cardiovascular disease. | Q37707281 | ||
| Transcriptional control of brown fat development | Q37726540 | ||
| Developmental origins of the adipocyte lineage: new insights from genetics and genomics studies. | Q37848703 | ||
| Human epicardial fat: what is new and what is missing? | Q37927148 | ||
| Epicardial fat: from the biomolecular aspects to the clinical practice | Q37941902 | ||
| Adiponectin: mechanistic insights and clinical implications | Q38017897 | ||
| Cellular cross-talk between epicardial adipose tissue and myocardium in relation to the pathogenesis of cardiovascular disease | Q38034934 | ||
| Meta-analysis of the relation of echocardiographic epicardial adipose tissue thickness and the metabolic syndrome | Q38049804 | ||
| Adiponectin receptor as a key player in healthy longevity and obesity-related diseases | Q38076906 | ||
| From the epicardial adipose tissue to vulnerable coronary plaques. | Q38106982 | ||
| The mechanisms linking adiposopathy to type 2 diabetes | Q38148498 | ||
| Adrenomedullin and cardiovascular diseases | Q38156783 | ||
| Epicardial adipose tissue in endocrine and metabolic diseases | Q38165864 | ||
| Overview of epidemiology and contribution of obesity to cardiovascular disease | Q38179543 | ||
| Nutrient regulation of insulin secretion and action | Q38199290 | ||
| Adrenomedullin and diabetes | Q38220819 | ||
| Adipose tissues as endocrine target organs. | Q38246467 | ||
| Interplay between the immune system and adipose tissue in obesity | Q38250282 | ||
| Maintenance of white adipose tissue in man. | Q38252822 | ||
| Adipocyte dysfunction, inflammation and metabolic syndrome | Q38262628 | ||
| Regulation of Pancreatic Beta Cell Stimulus-Secretion Coupling by microRNAs. | Q38266502 | ||
| Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk | Q38267491 | ||
| Brown adipose tissue and novel therapeutic approaches to treat metabolic disorders. | Q38272618 | ||
| Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory | Q38289787 | ||
| A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha | Q38321742 | ||
| The double role of epicardial adipose tissue as pro- and anti-inflammatory organ | Q40104456 | ||
| Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages | Q40212651 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1291537 | |
| P577 | publication date | 2016-04-26 | |
| P1433 | published in | Cardiology Research and Practice | Q26853980 |
| P1476 | title | Epicardial Fat: Physiological, Pathological, and Therapeutic Implications | |
| P478 | volume | 2016 |
| Q93077008 | A Western-type dietary pattern and atorvastatin induce epicardial adipose tissue interferon signaling in the Ossabaw pig |
| Q90682019 | Association between epicardial adipose tissue thickness and parameters of target organ damage in patients undergoing coronary angiography |
| Q97073579 | Association of epicardial fat thickness assessed by echocardiography with the severity of coronary artery disease |
| Q58803769 | Association of serum concentrations of irisin and the adipokines adiponectin and leptin with epicardial fat in cardiovascular surgery patients |
| Q64264965 | Coronary Artery Disease Is Associated with an Increased Amount of T Lymphocytes in Human Epicardial Adipose Tissue |
| Q64935007 | Dendritic Cells in Subcutaneous and Epicardial Adipose Tissue of Subjects with Type 2 Diabetes, Obesity, and Coronary Artery Disease. |
| Q102059107 | Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging |
| Q64965532 | Echocardiographic measurements of epicardial adipose tissue and comparative ability to predict adverse cardiovascular outcomes in patients with coronary artery disease. |
| Q92442696 | Effect of parathyroidectomy on epicardial fat thickness as a cardiovascular risk factor in patients with primary hyperparathyroidism |
| Q58737177 | Effects of antidiabetic drugs on epicardial fat |
| Q38949514 | Epicardial Adipose Tissue Removal Potentiates Outward Remodeling and Arrests Coronary Atherogenesis |
| Q89552208 | Epicardial Adipose Tissue, Adiponectin and Leptin: A Potential Source of Cardiovascular Risk in Chronic Kidney Disease |
| Q90464004 | Epicardial adipose tissue is a predictor of ascending aortic dilatation in hypertensive patients, but not paracardial adipose tissue |
| Q49676867 | Epicardial adipose tissue is related to arterial stiffness and inflammation in patients with cardiovascular disease and type 2 diabetes |
| Q89972232 | Impact of epicardial adipose tissue volume upon left ventricular dysfunction in patients with mild-to-moderate aortic stenosis: A post-hoc analysis |
| Q50025154 | Is there relationship between epicardial fat and cardiovascular parameters in incident kidney transplant patients? A post-hoc analysis. |
| Q37679243 | Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: a pilot study |
| Q91752993 | Presence of Intramyocardial Fat Tissue in the Right Atrium and Right Ventricle - Postmortem Human Analysis |
| Q52602292 | Proteostasis in epicardial versus subcutaneous adipose tissue in heart failure subjects with and without diabetes. |
| Q37736845 | Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes. |
| Q50052474 | Relationship between neutrophil/lymphocyte ratio and epicardial fat tissue thickness in patients with newly diagnosed hypertension |
| Q55252843 | Serum adiponectin and TNFα concentrations are closely associated with epicardial adipose tissue fatty acid profiles in patients undergoing cardiovascular surgery. |
| Q55239826 | The quest for immunotherapy in atherosclerosis: CANTOS study, interleukin-1β and vascular inflammation. |
| Q60921718 | The relation of novel cardiovascular risk parameters in patients with familial Mediterranean fever |
| Q47549529 | Thickness of carotid intima and epicardial fat in rosacea: a cross-sectional study |
Search more.